Peptide Receptor Radionuclide Therapy: An Emerging Treatment for Gastrointestinal Neuroendocrine Tumors
作者: Adria Myers Holly Renea Chitwood
刊名: Clinical Journal of Oncology Nursing, 2020, Vol.24 (2)
来源数据库: Oncology Nursing Society
DOI: 10.1188/20.CJON.129-133
关键词: Peptide receptor radionuclide therapy (PRRT)NeuroendocrineCarcinoid syndrome
原始语种摘要: Neuroendocrine tumors (NETs) are comprised of biologically diverse neoplasms. The presence of systemic symptoms is dependent on NET location and differentiation. New treatment modalities have become available, offering patients improved symptom management and survival. Advanced practice RNs (APRNs) provide direct care to and coordination of treatment for patients with NETs, including treatment of somatostatin receptor–positive disease with lutetium Lu 177 dotatate (Lutathera®) peptide receptor radionuclide therapy.
全文获取路径: PDF下载  ONS 
影响因子:0.91 (2012)

  • receptor 接受体
  • radionuclide 放射性核素
  • lutetium 
  • treatment 处理
  • coordination 配位
  • provide 规定
  • systemic 系统的
  • peptide 
  • survival 生存
  • including 包括(气导)包括……在内包括…在内